Furthermore, miR-10b exerted its oncogenic effects by directly targeting various tumor-associated genes, such as HOXD10, TBX5, KLF4, and PTEN, in breast cancer, pancreatic cancer, glioblastoma, and bladder cancer [12–19]. The gene discussed is HOXD10; the disease is breast carcinoma.